Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Strong antitumor effects demonstrated for humanized anti-TF monoclonal antibody

Nov. 21, 2003

ImmunoGen scientists design new prodrugs of CC-1065 analogues

Nov. 21, 2003

Merck presents three series of IGF-1R and IRR inhibitors

Nov. 21, 2003

Novel antiangiogenic agents revealed in recent Abbott patent

Nov. 20, 2003

Roche claims new c-Met kinase inhibitors and their use in cancer therapy

Nov. 20, 2003

Pivotal trial commences for Acapodene in advanced prostate cancer

Nov. 20, 2003

Italian phase III trial for ADI in liver cancer

Nov. 19, 2003

TopoTarget initiates phase I U.K. study of PXD-101

Nov. 17, 2003

Sanofi-Synthelabo presents new bFGF antagonists for cancer and other disorders

Nov. 17, 2003

New progesterone receptor modulators under investigation at Akzo Nobel

Nov. 17, 2003

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...